Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for RASAGILINE

Ingredient

RASAGILINE

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
APO-RASAGILINE	1MG	TABLET	Resolved	2017-03-11	2017-03-28	472
APO-RASAGILINE	0.5MG	TABLET	Resolved	2021-12-17	2022-09-01	151360
APO-RASAGILINE	0.5MG	TABLET	Resolved	2019-06-12	2019-08-30	86327
APO-RASAGILINE	0.5MG	TABLET	Resolved	2017-06-27	2017-11-13	14011
APO-RASAGILINE	0.5MG	TABLET	Resolved	2017-03-11	2017-03-28	469
JAMP RASAGILINE	1MG	TABLET	Actual shortage	2025-11-04	2026-01-27	271006
JAMP RASAGILINE	1MG	TABLET	Resolved	2025-11-04	2026-01-27	271003
JAMP RASAGILINE	0.5MG	TABLET	Resolved	2025-01-04	2025-06-16	246735
JAMP RASAGILINE	0.5MG	TABLET	Resolved	2025-01-04	2026-01-27	246733
JAMP RASAGILINE	0.5MG	TABLET	Resolved	2025-01-04	2025-08-04	246731

Showing 11 to 20 of 30

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
AZILECT	1MG	TABLET	Reversed	2025-05-28	2025-06-04	258705
AZILECT	1MG	TABLET	Reversed	2025-05-28	2025-06-04	258771
TEVA-RASAGILINE	1MG	TABLET	Reversed	2025-05-28	2025-06-04	258753

1

Showing 1 to 3 of 3